Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 7.52
-0.05 (-0.66%)
Aug 14, 2026, 5:00 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 121.54 million as of August 14, 2026. Its market cap has decreased by -20.84% in one year.
Market Cap
121.54M
Enterprise Value
139.93M
Revenue
17.61M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.52
ChartMarket Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 121.54M, an increase of 30.67%. That is a compound annual growth rate of 1.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 121.54M | 7.74% |
| Dec 30, 2025 | 112.81M | -21.57% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 580.49M |
| Captor Therapeutics Spolka Akcyjna | 461.89M |
| Bioceltix | 445.90M |
| Ryvu Therapeutics | 404.60M |
| BIOTON | 329.72M |
| Synthaverse | 223.90M |
| Poltreg | 159.15M |
| Molecure | 127.53M |